CVS CVS Health

XNYS Sideways Alert

Health Care

· How we analyze

About the company

CVS Health is a major US healthcare company. It runs thousands of pharmacies, the health insurer Aetna and, with Caremark, a pharmacy benefit manager. It also operates doctors’ offices and primary care. As of Oct 13, 2026

Fact sheet (from the annual report) Pharmacies and drugstores · Woonsocket, USA

The group offers health insurance, manages pharmacy benefits, runs stores and clinics and reports in the segments Health Care Benefits and Health Services, among others. Under the Aetna name, the insurance segment offers medical, dental and behavioral health plans as well as plans for the government programs Medicare and Medicaid. Members are insured mainly through employers, government programs or individually; sales run through its own employees as well as brokers, agents and consultants. Under CVS Caremark, the Health Services segment manages pharmacy benefits mainly for employers, insurers, unions and health plans, including mail-order and specialty pharmacies. This segment also includes the Oak Street Health primary care centers for members in the Medicare program as well as Signify Health.

Automatically summarized from SEC annual report (10-K, filed Feb 10, 2026) (website of the US Securities and Exchange Commission) · reviewed Oct 14, 2026

Price performance at a glance

Last 30 trading days
  • Today −1.5%
  • 7 days −3.8%
  • 30 days +2.2%
  • 1 year +10.5%
Day range (last trading day)
−0.2%Price at 9% of the range+2.1%
52-week range
−23.7%Price at 53% of the range+21.5%
Distance from the all-time high
−19.8%

Our own calculation from the exchange’s daily candles, as of Oct 27, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.

Fundamentals · Analysis method

Growth, margin and debt compared with the sector – in detail in the fundamental analysis further down. The chart shows the candles without a buy zone.

Growth: greenMargin: yellowDebt: gray

Load chart from TradingView

This transfers data (including your IP address) to TradingView, also to the USA. More in the Privacy policy.

Symbol on TradingView: NYSE:CVS

Fundamental analysis

CVS Health · Sector Health Care · amounts in USD

Information only – does not affect our buy zones, not investment advice. Source: SEC filings, As of Feb 10, 2026.

In short

  • Light green: Revenue grew over 5 years (+8.4% per year), at least as fast as the sector median.
  • Light red: Net income (total) shrank over 5 years (−24.4% per year); per share −23.9% per year.
  • Light yellow: Net margin 0.4%, below the sector median (12.9%).
  • Light yellow: Profit in 9 of 10 fiscal years.
  • Light red: Dividend higher than earnings.

Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.

RevenueNet income Net margin (below) in USD
  1. Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Revenue 177.5B USD · Net income 5.3B USD · Net margin 3.0%
  2. Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Revenue 184.8B USD · Net income 6.6B USD · Net margin 3.6%
  3. Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Revenue 194.6B USD · Net income −594.0M USD · Net margin −0.3%
  4. Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Revenue 256.8B USD · Net income 6.6B USD · Net margin 2.6%
  5. Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Revenue 268.7B USD · Net income 7.2B USD · Net margin 2.7%
  6. Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Revenue 292.1B USD · Net income 7.9B USD · Net margin 2.7%
  7. Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Revenue 322.5B USD · Net income 4.1B USD · Net margin 1.3%
  8. Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Revenue 357.8B USD · Net income 8.3B USD · Net margin 2.3%
  9. Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Revenue 372.8B USD · Net income 4.6B USD · Net margin 1.2%
  10. Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 402.1B USD · Net income 1.8B USD · Net margin 0.4%

Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 402.1B USD · Net income 1.8B USD · Net margin 0.4%

Key figures with traffic lights

Each light follows a simple, disclosed rule. The comparison is with the sector median of all 63 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).

Revenue growth

Light green: above sector

+8.4% per year, last 5 years

Sector Health Care: median +7.8% (60 symbols)

What does this mean? Revenue: over 5 years it grew by 8.4% per year on average – at least as fast as the median company in the sector (+7.8%).

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net income (total)

Light red: shrinking

−24.4% per year, last 5 years

Sector Health Care: median +7.5% (46 symbols)

per share: −23.9% per year (5 years, split-adjusted)

What does this mean? Total net income: over 5 years it fell by 24.4% per year on average. The median company in the sector reached +7.5% per year.

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net margin

Light yellow: below sector

0.4% last fiscal year

Sector Health Care: median 12.9% (63 symbols)

What does this mean? Of every 100 USD in revenue, 0.44 USD remained as profit – less than the median company in the sector (12.9%). Five years ago the margin was 2.7%.

Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.

Debt / equity

Light gray: not available

– latest balance sheet

Sector Health Care: median 0.66 (40 symbols)

What does this mean? No usable figure: reported financial debt or positive equity for the same balance sheet date is missing.

Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.

Payout ratio

Light red: above earnings

191% Dividend / earnings per share

Sector Health Care: median 28% (31 symbols)

What does this mean? The payout was higher than the earnings per share; it is paid from cash flow, from reserves or with new debt. Median company in the sector: 28%.

Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.

Profitable years

Light yellow: 1 loss year

9 of 10 fiscal years with a profit

What does this mean? In 9 of the last 10 fiscal years the bottom line showed a profit. One year ended with a loss.

Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).

Last fiscal year and 13F

Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
402.1B USD
Revenue vs. prior year
+7.8%
Net income (FY)
1.8B USD
Net income vs. prior year
−61.7%
EPS (FY)
1.39 USD
13F funds with a position
2 of 9
Funds vs. prior quarter
+1
Shares held vs. prior quarter
+241.9%
Fiscal year to Dec 31, 2025 · 10-K filed Feb 10, 2026 · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term). 13F: reporting date Jun 30, 2026, 9 tracked funds have filed (latest Aug 14, 2026), filed with up to 45 days of delay. Stock positions only; comparison with Mar 31, 2026 only across funds that filed for both quarters.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
YearEndRevenueNet income MarginEarnings per shareDividend per sharePayout
2025Dec 31, 2025 402.1B1.8B 0.4% 1.39 2.66 191%
2024Dec 31, 2024 372.8B4.6B 1.2% 3.66 2.66 73%
2023Dec 31, 2023 357.8B8.3B 2.3% 6.47 2.42 37%
2022Dec 31, 2022 322.5B4.1B 1.3% 3.14 2.20 70%
2021Dec 31, 2021 292.1B7.9B 2.7% 5.95 2.00 34%
2020Dec 31, 2020 268.7B7.2B 2.7% 5.46 2.00 37%
2019Dec 31, 2019 256.8B6.6B 2.6% 5.08 2.00 39%
2018Dec 31, 2018 194.6B−594.0M −0.3% −0.57 2.00 –
2017Dec 31, 2017 184.8B6.6B 3.6% 6.44 2.00 31%
2016Dec 31, 2016 177.5B5.3B 3.0% 4.90 1.70 35%
Quarters (amounts in USD, per share in USD)
QuarterEndRevenueNet income MarginEarnings per shareDividend per sharePayout
Q2/26Jun 30, 2026 106.1B3.0B 2.8% 2.31 0.67 29%
Q1/26Mar 31, 2026 100.4B2.9B 2.9% 2.30 0.67 29%
Q4/25*Dec 31, 2025 105.7B2.9B 2.8% – 0.67 –
Q3/25Sep 30, 2025 102.9B−4.0B −3.9% −3.13 0.67 –
Q2/25Jun 30, 2025 98.9B1.0B 1.0% 0.80 0.67 83%
Q1/25Mar 31, 2025 94.6B1.8B 1.9% 1.41 0.67 47%
Q4/24*Dec 31, 2024 97.7B1.6B 1.7% – 0.67 –
Q3/24Sep 30, 2024 95.4B87.0M 0.1% 0.07 0.67 950%
Q2/24Jun 30, 2024 91.2B1.8B 1.9% 1.41 0.67 47%
Q1/24Mar 31, 2024 88.4B1.1B 1.3% 0.88 0.67 76%
Q4/23*Dec 31, 2023 93.8B2.0B 2.2% – 0.61 –
Q3/23Sep 30, 2023 89.8B2.3B 2.5% 1.75 0.61 35%

* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.

How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.

Insiders

All insider transactions
Insider purchases and sales on the market over 3, 6 and 12 months
PeriodPurchasesSalesNet
3 months $00 people $00 people $0
6 months $00 people $323.7M2 people −$323.7M
12 months $00 people $323.7M2 people −$323.7M

Latest transactions

  • May 21, 2026 Robbins Larry Director Open-market sale 370,462 shares · $34.6M · SEC
  • May 20, 2026 Robbins Larry Director Open-market sale 800 shares · $77.0K · SEC
  • May 20, 2026 Robbins Larry Director Open-market sale 66,881 shares · $6.4M · SEC
  • May 20, 2026 Robbins Larry Director Open-market sale 152,691 shares · $14.5M · SEC
  • May 20, 2026 Robbins Larry Director Open-market sale 797,628 shares · $74.6M · SEC
  • May 19, 2026 Robbins Larry Director Open-market sale 151 shares · $14.4K · SEC

Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.

Trend score -5

Price vs. EMA 50-15
Price vs. EMA 200+15
EMA 50 vs. EMA 200+20
ADX (trend strength)+0
Highs and lows-10
Relative strength-15

Volatility and trend strength

ADX 14 (trend strength)20.7
Rel. strength 60 d−14.4%

ATR and moving averages as price values only when logged in.

More stocks from Health Care

All symbols in this sector

News

Latest news

Posts

No posts on CVS yet – log in to join the discussion.

Posts are opinions of users and only visible after logging in. Community rules

Set alert: CVS

Alerts with a free account: we send you an email as soon as the price moves above or below your level, reaches the buy zone or the buy zone becomes invalid.

Checked after every data update: crypto hourly (buy zones every 4 hours), stocks twice a day, precious metals every 4 hours on trading days, extended universe weekly – not in real time.

Log in Sign up free

↑ ↓ select · Enter open · Esc close